Official Publication of Houston Methodist DeBakey Heart & Vascular Center
IN THIS ISSUE
Guest Editors Henry Pownall and Antonio Gotto Offer Insight and Expertise on the topic of Lipids and Cardiovascular Disease
See MoreCholesterol: Can’t Live With It, Can’t Live Without It
How Much Do Lipid Guidelines Help the Clinician? Reading Between the (Guide)lines
Statins: Then and Now
Poststatin Lipid Therapeutics: A Review
HDL and Reverse Cholesterol Transport Biomarkers
Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability
High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes
Gene Delivery in Lipid Research and Therapies
Device-Related Thrombus: A Reason for Concern?
Retained Coronary Balloon Requiring Emergent Open Surgical Retrieval: An Uncommon Complication Requiring Individualized Management Strategies
Loperamide Mimicking Brugada Pattern
Reversed Pulsus Paradoxus in Right Ventricular Failure
Transcatheter Embolization of a Persistent Vertical Vein: A Rare Cause of Left-to-Right Shunt and Right-Sided Heart Failure
Addressing the Feedback Loop Between Depression, Diabetes, and Cardiovascular Disease
Letter to the Editor in response to “Role of Subcutaneous Leadless Implantable Cardioverter Defibrillator in Young Patients
Vol 15, Issue 1 (2019)
Showing results for keyword “ SGLT2 inhibitors”
Patricia Mejia Osuna Vol 14, Issue 4
Keywords: heart failure , type 2 diabetes , therapeutic options , DPP-4 inhibitors , GLP-1 agonists , SGLT2 inhibitorsOsuna PM, Brown SJ, Tabatabai LS, Hamilton DJ. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure. Methodist DeBakey Cardiovasc J. 2018;14(4):257-65.
